Loading clinical trials...
Loading clinical trials...
A Phase II Study With Decitabine, Low Dose Cytarabine and G-CSF in High-risk Myelodysplastic Syndromes, Refractory Acute Myeloid Leukemia or Acute Myeloid Leukemia in Patients With Significant Co-morbidities.
Conditions
Interventions
chemotherapy
Locations
1
United States
Lifespan Hospitals
Providence, Rhode Island, United States
Start Date
August 1, 2008
Primary Completion Date
February 1, 2010
Completion Date
April 1, 2010
Last Updated
January 14, 2022
NCT06735690
NCT00131014
NCT05564390
NCT03050268
NCT06074666
NCT07320235
Lead Sponsor
Brown University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions